{"id":"W2176098424","doi":"10.1016/j.bmcl.2004.11.021","title":"4-(2-Pyridyl)piperazine-1-benzimidazoles as potent TRPV1 antagonists","year":2004,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Ion Channels and Receptors","field":"Neuroscience","cited_by":47,"is_retracted":false,"has_abstract":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Chemistry; Piperazine; TRPV1; Antagonist; IC50; Benzimidazole; Capsaicin; Stereochemistry; Pharmacology; In vitro; Biochemistry; Receptor; Transient receptor potential channel; Organic chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000151521,0.0004024342,0.0003311599,0.00005632592,0.0003040741,0.00006665113,0.0005905669,0.0001736116,0.0008298645],"category_scores_gemma":[0.0002679765,0.0003318109,0.0001560567,0.0003280571,0.0004402621,0.0001258574,0.0001116938,0.0004658893,0.000483985],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002603586,"about_ca_system_score_gemma":0.0001722781,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006091544,"about_ca_topic_score_gemma":7.933717e-7,"domain_scores_codex":[0.997318,0.00003395976,0.0004159005,0.0007681397,0.0007781752,0.000685768],"domain_scores_gemma":[0.9990174,0.00005732,0.0001589585,0.0003423079,0.00003643249,0.0003876064],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00003941892,0.00009951434,0.00001490291,0.0000674444,0.00001010721,0.0003397192,0.0003301077,0.00003611041,0.9959349,0.00005617862,0.002600198,0.0004713886],"study_design_scores_gemma":[0.00130207,0.00004028504,0.00006550791,0.000109154,0.00002843275,0.0007498711,0.0002276144,0.00001206725,0.9910758,0.0001063681,0.005887809,0.0003950121],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9626945,0.0001524454,0.0001553615,0.03401387,0.001089747,0.0001698511,0.0000151563,0.0002253044,0.001483794],"genre_scores_gemma":[0.9880062,0.0001656456,0.00006045071,0.009974739,0.001398722,0.00001202778,0.00001763103,0.00005596195,0.000308625],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02531173,"threshold_uncertainty_score":0.9999134,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01380697168275361,"score_gpt":0.2378942708120587,"score_spread":0.2240872991293051,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}